Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Small Cancer Drug Makers Are on Fire
Seeking Alpha
Tuesday, August 4, 2009 - 9:47am
tags:
cancer, Ariad Pharmaceuticals, Oncothyreon, Spectrum Pharmaceuticals
Democrats May Bypass Republicans on Health Plan, Schumer Says
Bloomberg
Tuesday, August 4, 2009 - 9:46am
tags:
healthcare reform
Ziopharm Oncology: Deal or Dilution?
Seeking Alpha
Tuesday, August 4, 2009 - 9:34am
tags:
Zymafos, Zybulin, Ziopharm, Zinapar, cancer
VaxGen: Still a Good Prospect
Seeking Alpha
Tuesday, August 4, 2009 - 8:36am
tags:
VaxGen
Oncothyreon shares hit annual high on long-term data from study of Stimuvax in lung cancer
Yahoo/AP
Tuesday, August 4, 2009 - 8:35am
tags:
Oncothyreon, Stimuvax, lung cancer
Teva, Perrigo get FDA nod for allergy nasal spray
Globes,Israel
Tuesday, August 4, 2009 - 8:34am
tags:
Teva Pharmaceuticals, Perrigo Company, FDA, allergies, Sanofi, generics, Nasacort
Why pharma should embrace multi-level competition
PharmExec
Tuesday, August 4, 2009 - 8:11am
tags:
competition, pharma industry
New Diabetes Drug Could Give Januvia Stiff Competition
Seeking Alpha
Tuesday, August 4, 2009 - 7:49am
tags:
Merck, diabetes, Januvia, Bristol-Myers Squibb, AstraZeneca, Takeda, Forest Labs, OSI Pharmaceuticals, Novartis, Onglyza
Project Zero Delay Accelerates Drug's Path to Clinical Trial
Yahoo
Tuesday, August 4, 2009 - 7:44am
tags:
Project Zero, AstraZeneca, cancer
AstraZeneca Sells Symbicort Japan Rights to Astellas
Bloomberg
Tuesday, August 4, 2009 - 7:22am
tags:
Symbicort, Japan, Astellas
Antidepressant Use in U.S. Doubled Over Decade to 10% in 2005
Bloomberg
Monday, August 3, 2009 - 7:56pm
tags:
antidepressants, prescription data
Genzyme shares fall as rival Shire moves closer to market with genetic disorder treatment
Yahoo/AP
Monday, August 3, 2009 - 7:55pm
tags:
Genzyme, Shire, Cerezyme
MAP Pharmaceuticals cuts loss
Bizjournals.com
Monday, August 3, 2009 - 7:54pm
tags:
MAP Pharmaceuticals, earnings
Watson Pharma gets FDA approval for generic Toprol XL and says it will launch drug immediately
Yahoo/AP
Monday, August 3, 2009 - 7:52pm
tags:
Watson Pharmaceuticals, FDA, Toprol XL, generics, antihypertensives
THE INFLUENCE GAME: Biotech drug lobbying war
Yahoo/AP
Monday, August 3, 2009 - 7:45pm
tags:
biotech, lobbying
Merck, insurance plans settle Vioxx suits for $80M
Yahoo/AP
Monday, August 3, 2009 - 7:44pm
tags:
Merck, Vioxx, settlements
Merck's First Or Only Shot?
CNBC
Monday, August 3, 2009 - 7:42pm
tags:
Merck, buyouts, Schering Plough
GlaxoSmithKline's (Plague) Ship Comes In
Seeking Alpha
Monday, August 3, 2009 - 7:34pm
tags:
GSK, RELENZA, H1N1, swine flu
Healthcare reform passes House with pros, cons for pharma
Fierce Pharma
Monday, August 3, 2009 - 11:44am
tags:
healthcare reform
FDA Calendar Updates: Transcept Pharma Surges on Deal
Seeking Alpha
Monday, August 3, 2009 - 11:40am
tags:
FDA, Transcept, Intermezzo, Purdue

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.